Medicube Face Cream Flagged in Hong Kong Over Banned Sudan Dye
Hong Kong Customs has flagged Medicube's popular PDRN cream for containing banned Sudan dye, sparking a dispute over formulation safety and supply chain...
Archive
Hong Kong Customs has flagged Medicube's popular PDRN cream for containing banned Sudan dye, sparking a dispute over formulation safety and supply chain...
Shein's pre-IPO filings reveal a $99 million first-quarter loss, driven by a major accounting charge and the end of US de minimis tariff exemptions.
As beauty brands and manufacturers race to integrate artificial intelligence, a high-paying talent war is redefining roles across the global supply chain.
California's DTSC is cracking down on triphenyl phosphate in nail care and proposing a ban on hydrofluoric acid in cleaning products.
Estée Lauder is notifying current and former employees after a massive Oracle EBS security breach exposed sensitive personal, financial, and health data...
Chinese beauty giants Proya and Giant Biogene have backed Vicky Biotech's IPO, signaling a strategic race to secure proprietary peptide ingredients.
The UK beauty and personal care market contributed £28.3 billion to GDP in 2025, showing resilience despite inflation and post-Brexit trade barriers.
Rising anti-migrant unrest in South Africa threatens its status as Africa's premier cosmetics hub, forcing beauty brands to reassess supply chain risks.
As PDRN fast becomes the next blockbuster skincare ingredient, Bloomage Biotech is building a full-chain competitive barrier from synthesis to standard-setting.